IBDEI08H ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11207,0)
 ;;=379.23^^55^618^106
 ;;^UTILITY(U,$J,358.3,11207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11207,1,3,0)
 ;;=3^Vitreous Hemorrhage
 ;;^UTILITY(U,$J,358.3,11207,1,4,0)
 ;;=4^379.23
 ;;^UTILITY(U,$J,358.3,11207,2)
 ;;=Vitreous Hemorrhage^127096
 ;;^UTILITY(U,$J,358.3,11208,0)
 ;;=362.18^^55^618^89
 ;;^UTILITY(U,$J,358.3,11208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11208,1,3,0)
 ;;=3^Retinal Vasculitis
 ;;^UTILITY(U,$J,358.3,11208,1,4,0)
 ;;=4^362.18
 ;;^UTILITY(U,$J,358.3,11208,2)
 ;;=Retinal Vasculitis^264463
 ;;^UTILITY(U,$J,358.3,11209,0)
 ;;=360.21^^55^618^31
 ;;^UTILITY(U,$J,358.3,11209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11209,1,3,0)
 ;;=3^Degenerative Myopia
 ;;^UTILITY(U,$J,358.3,11209,1,4,0)
 ;;=4^360.21
 ;;^UTILITY(U,$J,358.3,11209,2)
 ;;=Degenerative Myopia^268553
 ;;^UTILITY(U,$J,358.3,11210,0)
 ;;=362.64^^55^618^80
 ;;^UTILITY(U,$J,358.3,11210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11210,1,3,0)
 ;;=3^Reticular Degeneration
 ;;^UTILITY(U,$J,358.3,11210,1,4,0)
 ;;=4^362.64
 ;;^UTILITY(U,$J,358.3,11210,2)
 ;;=Reticular Degeneration^268645
 ;;^UTILITY(U,$J,358.3,11211,0)
 ;;=362.61^^55^618^29
 ;;^UTILITY(U,$J,358.3,11211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11211,1,3,0)
 ;;=3^Degeneration, Paving Stone
 ;;^UTILITY(U,$J,358.3,11211,1,4,0)
 ;;=4^362.61
 ;;^UTILITY(U,$J,358.3,11211,2)
 ;;=Paving Stone Degeneration^268642
 ;;^UTILITY(U,$J,358.3,11212,0)
 ;;=362.42^^55^618^94
 ;;^UTILITY(U,$J,358.3,11212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11212,1,3,0)
 ;;=3^Rpe Detachment, Serous
 ;;^UTILITY(U,$J,358.3,11212,1,4,0)
 ;;=4^362.42
 ;;^UTILITY(U,$J,358.3,11212,2)
 ;;=Serous RPE Detachment^268633
 ;;^UTILITY(U,$J,358.3,11213,0)
 ;;=362.43^^55^618^93
 ;;^UTILITY(U,$J,358.3,11213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11213,1,3,0)
 ;;=3^Rpe Detachment, Hemorrhagic
 ;;^UTILITY(U,$J,358.3,11213,1,4,0)
 ;;=4^362.43
 ;;^UTILITY(U,$J,358.3,11213,2)
 ;;=Hemorrhagic RPE Detachment^268634
 ;;^UTILITY(U,$J,358.3,11214,0)
 ;;=250.00^^55^618^34
 ;;^UTILITY(U,$J,358.3,11214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11214,1,3,0)
 ;;=3^Dm Type II, No Retinopathy
 ;;^UTILITY(U,$J,358.3,11214,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,11214,2)
 ;;=DM Type II, No Retinopathy^33605
 ;;^UTILITY(U,$J,358.3,11215,0)
 ;;=250.01^^55^618^33
 ;;^UTILITY(U,$J,358.3,11215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11215,1,3,0)
 ;;=3^Dm Type I, No Retinopathy
 ;;^UTILITY(U,$J,358.3,11215,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,11215,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,11216,0)
 ;;=250.50^^55^618^25
 ;;^UTILITY(U,$J,358.3,11216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11216,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,11216,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,11216,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,11217,0)
 ;;=250.51^^55^618^27
 ;;^UTILITY(U,$J,358.3,11217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11217,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,11217,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,11217,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,11218,0)
 ;;=362.01^^55^618^32
 ;;^UTILITY(U,$J,358.3,11218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11218,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,11218,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,11218,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,11219,0)
 ;;=362.02^^55^618^72
 ;;^UTILITY(U,$J,358.3,11219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11219,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,11219,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,11219,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,11220,0)
 ;;=362.03^^55^618^64
 ;;^UTILITY(U,$J,358.3,11220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11220,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,11220,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,11220,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,11221,0)
 ;;=362.04^^55^618^61
 ;;^UTILITY(U,$J,358.3,11221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11221,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,11221,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,11221,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,11222,0)
 ;;=362.05^^55^618^62
 ;;^UTILITY(U,$J,358.3,11222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11222,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,11222,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,11222,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,11223,0)
 ;;=362.06^^55^618^98
 ;;^UTILITY(U,$J,358.3,11223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11223,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,11223,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,11223,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,11224,0)
 ;;=379.27^^55^618^103
 ;;^UTILITY(U,$J,358.3,11224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11224,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,11224,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,11224,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,11225,0)
 ;;=115.02^^55^618^44
 ;;^UTILITY(U,$J,358.3,11225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11225,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,11225,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,11225,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,11226,0)
 ;;=190.5^^55^618^58
 ;;^UTILITY(U,$J,358.3,11226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11226,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,11226,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,11226,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,11227,0)
 ;;=198.4^^55^618^59
 ;;^UTILITY(U,$J,358.3,11227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11227,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,11227,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,11227,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,11228,0)
 ;;=200.00^^55^618^81
 ;;^UTILITY(U,$J,358.3,11228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11228,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,11228,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,11228,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,11229,0)
 ;;=228.03^^55^618^38
 ;;^UTILITY(U,$J,358.3,11229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11229,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,11229,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,11229,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,11230,0)
 ;;=228.09^^55^618^39
 ;;^UTILITY(U,$J,358.3,11230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11230,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,11230,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,11230,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,11231,0)
 ;;=360.00^^55^618^73
 ;;^UTILITY(U,$J,358.3,11231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11231,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,11231,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,11231,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,11232,0)
 ;;=360.03^^55^618^21
 ;;^UTILITY(U,$J,358.3,11232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11232,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,11232,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,11232,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,11233,0)
 ;;=361.02^^55^618^76
 ;;^UTILITY(U,$J,358.3,11233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11233,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,11233,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,11233,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,11234,0)
 ;;=361.03^^55^618^75
 ;;^UTILITY(U,$J,358.3,11234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11234,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,11234,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,11234,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,11235,0)
 ;;=361.04^^55^618^79
 ;;^UTILITY(U,$J,358.3,11235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11235,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,11235,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,11235,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,11236,0)
 ;;=361.12^^55^618^8
 ;;^UTILITY(U,$J,358.3,11236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11236,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,11236,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,11236,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,11237,0)
 ;;=361.2^^55^618^102
 ;;^UTILITY(U,$J,358.3,11237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11237,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,11237,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,11237,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,11238,0)
 ;;=361.9^^55^618^83
 ;;^UTILITY(U,$J,358.3,11238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11238,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,11238,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,11238,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,11239,0)
 ;;=362.10^^55^618^95
 ;;^UTILITY(U,$J,358.3,11239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11239,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,11239,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,11239,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,11240,0)
 ;;=362.12^^55^618^22
 ;;^UTILITY(U,$J,358.3,11240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11240,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,11240,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,11240,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,11241,0)
 ;;=362.13^^55^618^88
 ;;^UTILITY(U,$J,358.3,11241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11241,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,11241,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,11241,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,11242,0)
 ;;=362.14^^55^618^82
 ;;^UTILITY(U,$J,358.3,11242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11242,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,11242,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,11242,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,11243,0)
 ;;=362.17^^55^618^52
